MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells

Glioma is the most common malignant tumor of the central nervous system with poor survival. Temozolomide (TMZ) is the first-line chemotherapy drug for initial and recurrent glioma treatment with a relatively good efficacy, which exerts its antitumor effects mainly through cell death induced by DNA d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Anticancer Drugs
Main Authors: Wang, Hongqin, Ren, Shuxian, Xu, Yongming, Miao, Wang, Huang, Xintao, Qu, Zhizhao, Li, Jinhu, Liu, Xiaodong, Kong, Pengzhou
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2019
Teme:
Preclinical Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6287895/
https://ncbi.nlm.nih.gov/pubmed/30273182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000700
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki